PepGen Inc.

PEPG

Find Out if You Qualify for a Financial Reward by filling out the form below.

PepGen Inc. Form












Stock Fraud Law Center does not share your information with others. There is no cost or obligation for you to submit.

Investigation Details

On July 30, 2024, PepGen released data from its ongoing Phase 2 trial of its drug candidate PGN-EDO51. On this news, PepGen stock fell over 45% during intraday trading on July 31, 2024.

Active Cases

Ticker Symbol Company Name Join Deadline Join
WOLF Wolfspeed, Inc. January 17, 2025 Join
SUI Sun Communities, Inc. February 10, 2025 Join
SAVA Cassava Sciences, Inc. February 10, 2025 Join
APLT Applied Therapeutics, Inc. February 18, 2025 Join